Metronidazole Injection

Generic name: Pronounced as (me troe ni' da zole)
Brand names
  • Flagyl® I.V.
  • Flagyl® I.V. RTU®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2016

Metronidazole injection can cause cancer in laboratory animals. Talk to your doctor about the risks and benefits of using this medication.

Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.

Antibiotics such as metronidazole injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.infections of the respiratory tract, including bronchitis, pneumonia

Metronidazole injection comes as a solution and is infused (injected slowly) intravenously (into a vein). It is usually infused over a period of 30 minutes to 1 hour every 6 hours. The length of treatment depends on the type of infection being treated. Your doctor will tell you how long to use metronidazole injection.

You may receive metronidazole injection in a hospital, or you may use the medication at home. If you will be using metronidazole injection at home, your health care provider will show you how to infuse the medication. Be sure that you understand these directions, and ask your healthcare provider if you have any questions.

You should begin to feel better during the first few days of treatment with metronidazole injection. If your symptoms do not improve or if they get worse, call your doctor.

Use metronidazole injection until you finish the prescription, even if you feel better. If you stop using metronidazole injection too soon or if you skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using metronidazole injection,

  • tell your doctor and pharmacist if you are allergic to metronidazole, any other medications, or any of the ingredients in metronidazole injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are have taken or are taking disulfiram (Antabuse). Your doctor will probably tell you not to use metronidazole injection if you are taking this medication or have taken it within the last 2 weeks.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven), busulfan (Buselfex, Myleran), cimetidine (Tagamet), corticosteroids, lithium (Lithobid), phenobarbital, and phenytoin (Dilantin, Phenytek). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with metronidazole injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have or have ever had Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever), a yeast infection, edema (fluid retention and swelling; excess fluid held in body tissues), or blood, kidney, or liver disease.

  • remember not to drink alcoholic beverages or take products with alcohol or propylene glycol while receiving metronidazole injection and for at least 3 days after treatment is finished. Alcohol and propylene glycol may cause nausea, vomiting, stomach cramps, headache, sweating, and flushing (redness of the face) when taken during treatment with metronidazole injection.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using metronidazole injection, call your doctor.

Unless your doctor tells you otherwise, continue your normal diet.

  • Metronidazole injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • loss of appetite

    • stomach pain and cramping

    • diarrhea

    • constipation

    • headache

    • irritability

    • depression

    • weakness

    • difficulty falling asleep or staying asleep

    • dry mouth; sharp, unpleasant metallic taste

    • furry tongue; mouth or tongue irritation

    • redness, pain, or swelling at the injection site

  • Some side effects can be serious. If you experience any of these symptoms, stop using metronidazole injection and call your doctor immediately:

    • rash

    • itching

    • hives

    • skin blistering, peeling, or shedding in the area

    • flushing

    • seizures

    • numbness, pain, burning, or tingling in your hands or feet

    • fever, eye sensitivity to light, stiff neck

    • difficulty speaking

    • problems with coordination

    • confusion

    • fainting

    • dizziness

  • Metronidazole injection may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Before having any laboratory test, tell your doctor and the laboratory personnel that you are receiving metronidazole injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Moxifloxacin.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Metronidazole.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Metronidazole.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Metronidazole.
Delavirdine Delavirdine The metabolism of Metronidazole can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Metronidazole.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Metronidazole.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Metronidazole.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Anagrelide.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Metronidazole.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Metronidazole.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Metronidazole.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Metronidazole can be decreased when combined with Erythromycin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Metronidazole.
Mycophenolate Mycophenolate The serum concentration of Mycophenolic acid can be decreased when it is combined with Metronidazole.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Metronidazole.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Acebutolol.
Prednisone Prednisone The metabolism of Metronidazole can be increased when combined with Prednisone.
Reserpine Reserpine The metabolism of Metronidazole can be increased when combined with Reserpine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Metronidazole.
Tizanidine Tizanidine The therapeutic efficacy of Metronidazole can be decreased when used in combination with Tizanidine.
Triamcinolone Triamcinolone The metabolism of Metronidazole can be increased when combined with Triamcinolone.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Metronidazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Metronidazole.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Metronidazole.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Metronidazole.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Metoclopramide.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Metronidazole.
Zidovudine Injection Zidovudine Injection The metabolism of Metronidazole can be increased when combined with Zidovudine.
Altretamine Altretamine The metabolism of Metronidazole can be decreased when combined with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Metronidazole.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Metronidazole.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Granisetron.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Metronidazole.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Metronidazole.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Metronidazole.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Metronidazole.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Metronidazole.
Oxcarbazepine Oxcarbazepine The metabolism of Metronidazole can be increased when combined with Oxcarbazepine.
Zaleplon Zaleplon The therapeutic efficacy of Zaleplon can be decreased when used in combination with Metronidazole.
Anakinra Anakinra The metabolism of Metronidazole can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Desloratadine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Metronidazole.
Etanercept Injection Etanercept Injection The metabolism of Metronidazole can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Metronidazole can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Metronidazole.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Metronidazole.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Metronidazole.
Eplerenone Eplerenone The metabolism of Metronidazole can be decreased when combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Escitalopram.
Zonisamide Zonisamide The therapeutic efficacy of Metronidazole can be decreased when used in combination with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Metronidazole can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Metronidazole.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Metronidazole.
Atazanavir Atazanavir The metabolism of Metronidazole can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Metronidazole.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Metronidazole.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Metronidazole.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Metronidazole.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Metronidazole.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Metronidazole.
Aprepitant Aprepitant The metabolism of Metronidazole can be decreased when combined with Aprepitant.
Memantine Memantine The metabolism of Metronidazole can be decreased when combined with Memantine.
Tadalafil Tadalafil The metabolism of Metronidazole can be decreased when combined with Tadalafil.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Metronidazole.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Metronidazole.
Infliximab Injection Infliximab Injection The metabolism of Metronidazole can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Metronidazole.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Metronidazole.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Metronidazole.
Bosentan Bosentan The metabolism of Bosentan can be decreased when combined with Metronidazole.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Metronidazole.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Metronidazole.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Solifenacin.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Metronidazole.
Dextroamphetamine Dextroamphetamine The metabolism of Metronidazole can be decreased when combined with Amphetamine.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Metronidazole.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Metronidazole.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Metronidazole.
Pregabalin Pregabalin The therapeutic efficacy of Pregabalin can be decreased when used in combination with Metronidazole.
Deferasirox Deferasirox The metabolism of Metronidazole can be decreased when combined with Deferasirox.
Tipranavir Tipranavir The risk or severity of adverse effects can be increased when Metronidazole is combined with Tipranavir.
Felbamate Felbamate The therapeutic efficacy of Felbamate can be decreased when used in combination with Metronidazole.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Metronidazole can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Metronidazole can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Metronidazole.
Gefitinib Gefitinib The metabolism of Metronidazole can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Salbutamol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Metronidazole.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Posaconazole.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Primaquine.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dimenhydrinate.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Metronidazole.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Metronidazole can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Metronidazole.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Metronidazole.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Metronidazole.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Metronidazole.
Armodafinil Armodafinil The metabolism of Metronidazole can be increased when combined with Armodafinil.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Metronidazole.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Metronidazole.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Bexarotene can be decreased when combined with Metronidazole.
Budesonide Budesonide The metabolism of Metronidazole can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Metronidazole can be decreased when combined with Chloramphenicol.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Metronidazole.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Arsenic trioxide.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Metronidazole.
Pilocarpine Pilocarpine The metabolism of Metronidazole can be decreased when combined with Pilocarpine.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Metronidazole can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Metronidazole.
Irinotecan Injection Irinotecan Injection The metabolism of Metronidazole can be decreased when combined with Irinotecan.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Metronidazole.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Metronidazole.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Metronidazole.
Eltrombopag Eltrombopag The metabolism of Metronidazole can be decreased when combined with Eltrombopag.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Betaxolol.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Metronidazole.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Metronidazole.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Metronidazole.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Metronidazole.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Metronidazole.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Metronidazole.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Metronidazole.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Metronidazole.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Metronidazole.
Golimumab Injection Golimumab Injection The metabolism of Metronidazole can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Metronidazole.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Asenapine.
Vigabatrin Vigabatrin The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Metronidazole.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Metronidazole.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Metronidazole.
Levonorgestrel Levonorgestrel The metabolism of Metronidazole can be decreased when combined with Levonorgestrel.
Tocilizumab Injection Tocilizumab Injection The metabolism of Metronidazole can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Metronidazole is combined with Dalfampridine.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Metronidazole.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Metronidazole can be decreased when combined with Acetaminophen.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Metronidazole.
Busulfan Injection Busulfan Injection The serum concentration of Busulfan can be increased when it is combined with Metronidazole.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Metronidazole.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Metronidazole.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Metronidazole can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Metronidazole.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Triptorelin.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Metronidazole.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Metronidazole.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Metronidazole.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Metronidazole.
Clobazam Clobazam The therapeutic efficacy of Clobazam can be decreased when used in combination with Metronidazole.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Metronidazole.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Metronidazole.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Metronidazole.
Crizotinib Crizotinib The metabolism of Metronidazole can be decreased when combined with Crizotinib.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Metronidazole.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Metronidazole.
Ezogabine Ezogabine The therapeutic efficacy of Tiagabine can be decreased when used in combination with Metronidazole.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Metronidazole.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Metronidazole can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Metronidazole.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Metronidazole.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bedaquiline.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Metronidazole.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Metronidazole.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Metronidazole.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Metronidazole.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Metronidazole.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Metronidazole.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Metronidazole.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Metronidazole.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Metronidazole.
Perampanel Perampanel The therapeutic efficacy of Perampanel can be decreased when used in combination with Metronidazole.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Metronidazole.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Metronidazole.
Ketorolac Injection Ketorolac Injection The metabolism of Ketorolac can be decreased when combined with Metronidazole.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Metronidazole.
Apremilast Apremilast The metabolism of Metronidazole can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Metronidazole.
Siltuximab Injection Siltuximab Injection The metabolism of Metronidazole can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Metronidazole.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Metronidazole.
Testosterone Injection Testosterone Injection The metabolism of Metronidazole can be decreased when combined with Testosterone.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Metronidazole.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Metronidazole.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Metronidazole.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Metronidazole.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Metronidazole.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Metronidazole.
Secukinumab Injection Secukinumab Injection The metabolism of Metronidazole can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Metronidazole.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Metronidazole.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lenvatinib.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Metronidazole.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ivabradine.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Metronidazole.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Metronidazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ziprasidone.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Metronidazole.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Metronidazole.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Metronidazole.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Metronidazole.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Metronidazole.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Metronidazole.
Dexamethasone Injection Dexamethasone Injection The metabolism of Metronidazole can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Metronidazole.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Metronidazole.
Cobicistat Cobicistat The metabolism of Metronidazole can be decreased when combined with Cobicistat.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Metronidazole.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Metronidazole.
Rucaparib Rucaparib The metabolism of Metronidazole can be decreased when combined with Rucaparib.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Metronidazole.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Metronidazole.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Metronidazole.
Deflazacort Deflazacort The metabolism of Metronidazole can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Metronidazole can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Metronidazole can be decreased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Metronidazole.
Enasidenib Enasidenib The metabolism of Metronidazole can be decreased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Metronidazole.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Metronidazole.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Metronidazole.
Acalabrutinib Acalabrutinib The metabolism of Metronidazole can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Metronidazole can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The metabolism of Metronidazole can be decreased when combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Metronidazole.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Metronidazole.
Fostamatinib Fostamatinib The metabolism of Metronidazole can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Metronidazole.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Metronidazole.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Encorafenib.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Metronidazole.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Metronidazole.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Metronidazole.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Metronidazole.
Dacomitinib Dacomitinib The metabolism of Metronidazole can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Metronidazole.
Stiripentol Stiripentol The therapeutic efficacy of Stiripentol can be decreased when used in combination with Metronidazole.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Metronidazole.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Metronidazole.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Metronidazole.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Metronidazole.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Metronidazole can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Metronidazole.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Metronidazole.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Metronidazole.
Brexanolone Injection Brexanolone Injection The therapeutic efficacy of Brexanolone can be decreased when used in combination with Metronidazole.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Metronidazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Entrectinib.
Pexidartinib Pexidartinib The metabolism of Metronidazole can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Metronidazole.
Pitolisant Pitolisant Metronidazole may increase the QTc-prolonging activities of Pitolisant.
Lefamulin Lefamulin Metronidazole may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The serum concentration of Metronidazole can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Metronidazole can be decreased when it is combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Metronidazole.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Metronidazole.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Metronidazole.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Metronidazole.
Cenobamate Cenobamate The serum concentration of Metronidazole can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Metronidazole.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Metronidazole.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Metronidazole.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Metronidazole.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fostemsavir.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Metronidazole.
Pralsetinib Pralsetinib The metabolism of Metronidazole can be decreased when combined with Pralsetinib.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Metronidazole.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Metronidazole.
Indomethacin Indomethacin The metabolism of Indomethacin can be decreased when combined with Metronidazole.
Mefenamic Acid Mefenamic Acid The metabolism of Mefenamic acid can be decreased when combined with Metronidazole.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Metronidazole.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Metronidazole.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Metronidazole.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Metronidazole.
Primidone Primidone The metabolism of Metronidazole can be increased when combined with Primidone.
Methsuximide Methsuximide The therapeutic efficacy of Methsuximide can be decreased when used in combination with Metronidazole.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Metronidazole.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Metronidazole.
Flurazepam Flurazepam The metabolism of Metronidazole can be decreased when combined with Flurazepam.
Clorazepate Clorazepate The therapeutic efficacy of Clorazepic acid can be decreased when used in combination with Metronidazole.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Metronidazole.
Tranylcypromine Tranylcypromine The metabolism of Metronidazole can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Metronidazole can be decreased when combined with Phenelzine.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Thioridazine.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Metronidazole.
Sulfadiazine Sulfadiazine The metabolism of Sulfadiazine can be decreased when combined with Metronidazole.
Oxycodone Oxycodone The metabolism of Metronidazole can be decreased when combined with Oxycodone.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Metronidazole.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Metronidazole.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Maprotiline.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Metronidazole.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Orphenadrine.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Metronidazole.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Metronidazole.
Hydrocortisone Hydrocortisone The metabolism of Metronidazole can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Metronidazole.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Metronidazole.
Clonidine Clonidine The metabolism of Metronidazole can be decreased when combined with Clonidine.
Cimetidine Cimetidine The metabolism of Metronidazole can be decreased when combined with Cimetidine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Metronidazole.
Clonazepam Clonazepam The therapeutic efficacy of Clonazepam can be decreased when used in combination with Metronidazole.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Metronidazole.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Promethazine.
Daunorubicin Daunorubicin The metabolism of Metronidazole can be increased when combined with Daunorubicin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Metronidazole.
Mebendazole Mebendazole The risk or severity of adverse effects can be increased when Mebendazole is combined with Metronidazole.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Metronidazole.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Metronidazole.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Metronidazole.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Metronidazole.
Secobarbital Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Metronidazole.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Metronidazole.
Imipramine Imipramine The risk or severity of QTc prolongation can be increased when Imipramine is combined with Metronidazole.
Probenecid Probenecid The metabolism of Metronidazole can be decreased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Metronidazole.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Procainamide.
Isoniazid Isoniazid The metabolism of Metronidazole can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Metronidazole can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Metronidazole.
Methimazole Methimazole The metabolism of Metronidazole can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Metronidazole.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Metronidazole.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Metronidazole.
Dextromethorphan Dextromethorphan The metabolism of Metronidazole can be decreased when combined with Dextromethorphan.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Metronidazole.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Metronidazole.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Metronidazole.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone The metabolism of Metronidazole can be decreased when combined with Chlorzoxazone.
Disulfiram Disulfiram The risk or severity of adverse effects can be increased when Metronidazole is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Propranolol is combined with Metronidazole.
Nortriptyline Nortriptyline The metabolism of Metronidazole can be decreased when combined with Nortriptyline.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Metronidazole.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Metronidazole.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Metronidazole.
Acetazolamide Acetazolamide The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Metronidazole.
Ketoconazole Ketoconazole The metabolism of Metronidazole can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Metronidazole.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Metronidazole.
Vincristine Injection Vincristine Injection The metabolism of Metronidazole can be decreased when combined with Vincristine.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Metronidazole.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Metronidazole.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Metronidazole.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Thiothixene.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Metronidazole.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Metronidazole.
Triazolam Triazolam The metabolism of Metronidazole can be decreased when combined with Triazolam.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Metronidazole.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Metronidazole.
Diltiazem Diltiazem The metabolism of Metronidazole can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Metronidazole.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Metronidazole.
Piroxicam Piroxicam The metabolism of Piroxicam can be decreased when combined with Metronidazole.
Etoposide Etoposide The metabolism of Metronidazole can be decreased when combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Metronidazole.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Metronidazole.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Metronidazole.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pentamidine.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Metronidazole can be decreased when combined with Gemfibrozil.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Metronidazole.
Flurbiprofen Flurbiprofen The metabolism of Metronidazole can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Metronidazole.
Buspirone Buspirone The metabolism of Metronidazole can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Metronidazole.
Ciprofloxacin Ciprofloxacin The metabolism of Metronidazole can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Metronidazole.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nimodipine.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Clozapine.
Estazolam Estazolam The therapeutic efficacy of Estazolam can be decreased when used in combination with Metronidazole.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Metronidazole.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ofloxacin.
Clarithromycin Clarithromycin The metabolism of Metronidazole can be decreased when combined with Clarithromycin.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Metronidazole.
Felodipine Felodipine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Felodipine.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Metronidazole.
Simvastatin Simvastatin The metabolism of Metronidazole can be decreased when combined with Simvastatin.
Teniposide Injection Teniposide Injection The metabolism of Metronidazole can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Metronidazole can be decreased when combined with Itraconazole.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sotalol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Metronidazole.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Metronidazole.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metronidazole.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Metronidazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cisapride.
Gabapentin Gabapentin The therapeutic efficacy of Gabapentin can be decreased when used in combination with Metronidazole.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Metronidazole.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Metronidazole.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Metronidazole.
Fluvoxamine Fluvoxamine The metabolism of Metronidazole can be decreased when combined with Fluvoxamine.
Lamotrigine Lamotrigine The metabolism of Metronidazole can be increased when combined with Lamotrigine.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Metronidazole.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Metronidazole.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Metronidazole.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Metronidazole.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Metronidazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Metronidazole.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Metronidazole.
Bupropion Bupropion The risk or severity of seizure can be increased when Bupropion is combined with Metronidazole.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Metronidazole.
Saquinavir Saquinavir The metabolism of Metronidazole can be decreased when combined with Saquinavir.
Nisoldipine Nisoldipine The metabolism of Metronidazole can be decreased when combined with Nisoldipine.
Riluzole Riluzole The therapeutic efficacy of Riluzole can be decreased when used in combination with Metronidazole.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Metronidazole.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Metronidazole.
Indinavir Indinavir The metabolism of Metronidazole can be decreased when combined with Indinavir.
Ritonavir Ritonavir The risk or severity of adverse effects can be increased when Ritonavir is combined with Metronidazole.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Metronidazole.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Metronidazole.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Metronidazole.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Metronidazole.
Topiramate Topiramate The therapeutic efficacy of Topiramate can be decreased when used in combination with Metronidazole.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Metronidazole.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Metronidazole.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Metronidazole.
Nelfinavir Nelfinavir The metabolism of Metronidazole can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Metronidazole.
Flutamide Flutamide The metabolism of Metronidazole can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Metronidazole.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Metronidazole.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Metronidazole.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Propafenone.
Letrozole Letrozole The metabolism of Metronidazole can be decreased when combined with Letrozole.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Metronidazole.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Metronidazole.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Metronidazole.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Citalopram.
Capecitabine Capecitabine The serum concentration of the active metabolites of Capecitabine can be increased when Capecitabine is used in combination with Metronidazole.
Efavirenz Efavirenz The metabolism of Metronidazole can be increased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Metronidazole.
Pioglitazone Pioglitazone The metabolism of Pioglitazone can be decreased when combined with Metronidazole.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Metronidazole.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Metronidazole.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Metronidazole.
Thalidomide Thalidomide The metabolism of Thalidomide can be decreased when combined with Metronidazole.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Metronidazole.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Metronidazole.
Levetiracetam Levetiracetam The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Metronidazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Metronidazole.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists